Boehringer, VTU Technology renew deal for new therapeutic proteins
The agreement will give Boehringer access to VTU’s yield-enhancing Pichia pastoris expression platform to develop and manufacture therapeutic proteins. The platform is based on VTU’s AOX1 promoter libraries